A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

Clinical trial NCT07518043 · RECRUITING

Trial details

NCT number: NCT07518043
Sponsor: Shanghai Henlius Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal and/or Cardia Cancer Melanoma Urothelial Carcinoma (UC)

Start date: 2026-07-15
Primary completion: 2027-08-12
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.